← Open Payments lookup

KAMEALYA FARRELL: Open Payments

NPI 1215462999 · SULLIVAN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,377 in 78 payments from 19 companies in 2025. Trend: 2023 $843 · 2024 $1,032 · 2025 $1,377

Food & beverage: $1,377
CompanyPaymentsAmount
ABBVIE INC.25$358
Novo Nordisk Inc12$170
AstraZeneca Pharmaceuticals LP5$147
SANOFI-AVENTIS U.S. LLC3$93
Otsuka America Pharmaceutical, Inc.4$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$85
Lilly USA, LLC3$68
Gilead Sciences, Inc.3$62
Exact Sciences Corporation3$58
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$57

Products named: VRAYLAR, AIRSUPRA, QULIPTA, TZIELD, REXULTI, CAPLYTA, MOUNJARO, Ozempic.

Industry payments across MO — which companies pay providers there.